Difference between revisions of "EGILA"
(Created page with "LncRNA DLGAP1 antisense RNA 2 (DLGAP1-AS2),one kind cytoplasmic long non-coding RNA,was up-regulated in glioma and was quite correlated with poor prognosis of glioma patients....") |
|||
| Line 6: | Line 6: | ||
Approved name:EGFR interacting lncRNA | Approved name:EGFR interacting lncRNA | ||
| − | HGNC ID | + | HGNC ID :54482 |
===Characteristics=== | ===Characteristics=== | ||
| Line 32: | Line 32: | ||
==References== | ==References== | ||
<references> | <references> | ||
| − | <ref name="ref1">Jiang R, Tang J, Chen Y, Deng L, Ji J, Xie Y, Wang K, Jia W, Chu WM, Sun B. The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion. Nat Commun. 2017 May 25;8:15129. doi: 10.1038/ncomms15129. </ | + | <ref name="ref1">Jiang R, Tang J, Chen Y, Deng L, Ji J, Xie Y, Wang K, Jia W, Chu WM, Sun B. The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion. Nat Commun. 2017 May 25;8:15129. doi: 10.1038/ncomms15129. </ref1> |
</references> | </references> | ||
Latest revision as of 10:41, 19 February 2021
LncRNA DLGAP1 antisense RNA 2 (DLGAP1-AS2),one kind cytoplasmic long non-coding RNA,was up-regulated in glioma and was quite correlated with poor prognosis of glioma patients.
Contents
Annotated Information
Name
Approved symbol:EGILA
Approved name:EGFR interacting lncRNA
HGNC ID :54482
Characteristics
Please input information here.
Function
The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion [1].
Regulation
Lnc-EGFR links an immunosuppressive state to cancer by promoting Treg cell differentiation[2].
Expression
Nc-EGFR specifically binds to EGFR and blocks its interaction with and ubiquitination by c-CBL, stabilizing it and augmenting activation of itself and its downstream AP-1/NF-AT1 axis, which in turn elicits EGFR expression[2].
Diseases
- Please input information here.
Labs working on this lncRNA
- Liver Transplantation Center of the First Affiliated Hospital and Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu Province 210029, P.R. China[2].
- Department of Microbiology and Immunology, Nanjing Medical University, Nanjing, Jiangsu Province 210029, P.R. China[2].
- Metabolomics Shared Resource, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, Hawaii 96813, USA[2].
- Cancer Biology Program, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, Hawaii 96813, USA.[2].
